- Home
- SCSC vs CERT Comparison
SCSC vs CERT Comparison
Compare SCSC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCSC | CERT |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.2M | 860.9M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCSC | CERT |
|---|---|---|
| Price | $42.88 | $4.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $43.00 | $11.67 |
| AVG Volume (30 Days) | 220.2K | ★ 2.8M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $3,846,260,000.00 | $418,838,000.00 |
| Revenue This Year | $2.60 | $4.18 |
| Revenue Next Year | $4.01 | $5.39 |
| P/E Ratio | $17.47 | ★ N/A |
| Revenue Growth | 7.79 | ★ 8.75 |
| 52 Week Low | $33.76 | $4.80 |
| 52 Week High | $46.64 | $13.88 |
Technical Indicators
Market Signals| Indicator | SCSC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 57.83 | 24.55 |
| Support Level | $42.71 | N/A |
| Resistance Level | $42.93 | $6.48 |
| Average True Range (ATR) | 1.76 | 0.33 |
| MACD | 0.03 | -0.16 |
| Stochastic Oscillator | 41.97 | 0.27 |
Price Performance
Historical ComparisonAbout SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.